Back to search

Daunomycin-induced cardiotoxicity in children and adults

Data up to Jan 2025

Published1977
Citations428
References17
Clinical Trials (1)

Total Citations Per Year

Abstract

References (17)

A clinicopathologic analysis of adriamycin cardiotoxicity

1973 • 1,534 citations

Statistical Methods in Medical Research

1972 • 620 citations

Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemia

1967 • 470 citations

CARDIAC TOXICITY OF DAUNORUBICIN

1969 • 345 citations

The cardiotoxicity of adriamycin and daunomycin in children

1976 • 168 citations

Chemotherapy of acute lymphocytic leukemia of childhood

1972 • 111 citations

Daunorubicin in the therapy of acute granulocytic leukemia.

1973 • 108 citations

Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).

1973 • 89 citations

Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia

1974 • 83 citations

ACUTE LYMPHOBLASTIC LEUKÆMIA TREATED WITH A COMBINATION OF PREDNISONE, VINCRISTINE, AND RUBIDOMYCIN

1967 • 66 citations

Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.

1971 • 35 citations

Clinical Study of Daunomycin and Prednisone for Induction of Remission in Children with Advanced Leukemia

1969 • 35 citations

Acute leukemia treatment.

1967 • 33 citations

DAUNORUBICIN IN ACUTE MYELOCYTIC LEUKqMIA

1969 • 30 citations

Clinical study of daunomycin (NSC-82151) in children with acute leukemia

1968 • 29 citations

[Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases].

1967 • 24 citations

Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.

1968 • 8 citations

Cited By (0)

Loading...
Daunomycin-induced cardiotoxicity in children and adults (1977) – The American Journal of Medicine | Metascience Observatory Explorer